Dogs vaccinated with gentamicin-attenuated Leishmania infantum or infected with wild-type parasite can be distinguished by Western blotting

Parasite Immunology

Volumn 36, Issue 5, 2014, Pages 218-224

  Daneshvar, H ^a   Mahmmodi, Z ^a   Kamiabi, H ^b   Phillips, R S ^c   Burchmore, R ^c  

^a KERMAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b KERMAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

Distinguishing; Dogs; Gentamicin attenuated Leishmania infantum; Vaccine; Western blot

Indexed keywords

GENTAMICIN; IMMUNOGLOBULIN G ANTIBODY; LEISHMANIA VACCINE;

ANIMAL EXPERIMENT; ANTIBODY TITER; ANTIGEN RECOGNITION; ARTICLE; CONTROLLED STUDY; EXPERIMENTAL DOG; FEMALE; LEISHMANIA INFANTUM; MALE; NONHUMAN; PRIORITY JOURNAL; PROMASTIGOTE; VACCINATION; VISCERAL LEISHMANIASIS; WESTERN BLOTTING; WILD TYPE;

DISTINGUISHING; DOGS; GENTAMICIN-ATTENUATED LEISHMANIA INFANTUM; VACCINE; WESTERN BLOT;

ANIMALS; ANTIBODIES, PROTOZOAN; ANTIGENS, PROTOZOAN; BLOTTING, WESTERN; DOG DISEASES; DOGS; FEMALE; GENTAMICINS; IMMUNOGLOBULIN G; LEISHMANIA INFANTUM; LEISHMANIASIS, VISCERAL; MALE; VACCINATION;

EID: 84897935727     PISSN: 01419838     EISSN: 13653024     Source Type: Journal    
DOI: 10.1111/pim.12108     Document Type: Article

References (27)

1. Pearson RD & Sousa AQ. Clinical spectrum of leishmaniasis. Clin Infect Dis 1996; 22: 1-13.
2. Palatnik-de-Sousa CB, dos Santos WR, Franca-Silva JC, et al. Impact of canine control on the epidemiology of canine and human visceral leishmaniasis in Brazil. Am J Trop Med Hyg 2001; 65: 510-517.
3. Sundar S. Drug resistance in Indian visceral leishmaniasis. Tro Med Int Health 2001; 6: 849-854.
4. Sereno D, Guilvard E, Maquaire S, et al. Experimental studies on the evolution of antimony-resistant phenotype during the in vitro life cycle of Leishmania infantum: implications for the spread of chemoresistance in endemic areas. Acta Trop 2001; 80: 195-205.
5. Daneshvar H, Coombs GH, Hagan P & Phillips RS. Leishmania mexicana and Leishmania major: attenuation of wild-type parasites and vaccination with attenuated lines. J Infect Dis 2003; 187: 1662-1668.
6. Daneshvar H, Wyllie S, Phillips RS, Hagan P & Burchmore R. Comparative proteomics profiling of a gentamicin-attenuated Leishmania infantum cell line identifies key changes in parasite thiol-redox metabolism. J Proteomics 2012; 75: 1463-1471.
7. Romao S, Castro H, Sousa C, Carvalho S & Tomás AM. The cytosolic tryparedoxin of Leishmania infantum is essential for parasite survival. Int J Parasitol 2009; 39: 703-711.
8. Castro H, Budde H, Flohe' L, et al. Specificity and kinetics of a mitochondrial peroxiredoxin of Leishmania infantum. Free Radic Biol Med 2002; 33: 1563-1574.
9. Daneshvar H, Molaei MM, Kamiabi H, Burchmore R, Hagan P & Phillips RS. Gentamicin attenuated Leishmania infantum: cellular immunity production and protection of dogs against experimental canine leishmaniasis. Parasite Immunol 2010; 32: 722-730.
10. Daneshvar H, Namazi MJ, Kamiabi H, Burchmore R, Cleaveland S & Phillips RS. Gentamicin-attenuated Leishmania infantum vaccine: protection of dogs against canine visceral leishmaniasis in endemic area of southeast of Iran. PLoS Negl Trop Dis 2014; DOI: 10.1371/journal.pntd.0002757.
11. Marty P, Lelièvre A, Quaranta JF, et al. Detection by Western blot of four antigens characterizing acute clinical leishmaniasis due to Leishmania infantum. Trans R Soc Trop Med Hyg 1995; 89: 690-691.
12. Rodgers MR, Poper SJ & Wirth DF. Amplification of kinetoplast DNA as a tool in the detection and diagnosis of Leishmania. Exp Parasitol 1990; 71: 267-275.
13. Tafuri WL, de Oliveira MR, Melo MN & Tafuri WL. Canine visceral leishmaniasis: a remarkable histopathological picture of one case reported from Brazil. Vet Parasitol 2001; 96: 203-212.
14. Carrera L, Fermi'n ML, Tesouro M, et al. Antibody response in dogs experimentally infected with Leishmania infantum: infection course antigen markers. Exp Parasitol 1996; 82: 139-146.
15. Fernandez-Pe-rez FJ, Mendez S, de la Fuente C, Cuquerella M, Gomez MT & Alunda JM. Value of Western blotting in the clinical follow-up of canine leishmaniasis. J Vet Diagn Invest 1999; 11: 170-173.
16. Daneshvar H, Molaei MM, Afshar RM, et al. Gentamicin attenuated Leishmania infantum: clinicopathological study in dogs. Vet Immunol Immunopathol 2009; 129: 28-35.
17. Borja-Cabrera GP, da Silva VO, da Costa RT, et al. The FML-ELISA assay in diagnosis and prognosis of canine visceral leishmaniasis. Am J Trop Med Hyg 1999; 6: 296-301.
18. de Oliveira MC, Paraguai De Souza E, Borja-Cabrera GP, et al. IgG1/IgG2 antibody dichotomy in sera of vaccinated or naturally infected dogs with visceral leishmaniasis. Vaccine 2003; 21: 2589-2597.
19. Lemesre JL, Holzmuller P, Cavaleyra M, Goncalvesa RB, Hottinb G & Papierok G. Protection against experimental visceral leishmaniasis infection in dogs immunized with purified excreted secreted antigens of Leishmania infantum promastigotes. Vaccine 2005; 23: 2825-2840.
20. Santarém N, Tomás A, Ouaissi A, et al. Antibodies against a Leishmania infantum peroxiredoxin as a possible marker for diagnosis of visceral leishmaniasis and for monitoring the efficacy of treatment. Immunol Lett 2005; 101: 18-23.
21. Kima PE, Bonilla JA, Cho E, et al. Identification of Leishmania proteins preferentially released in infected cells using change mediated antigen technology (CMAT). PLoS Negl Trop Dis 2010; 4: e842.
22. Walker J, Acestor N, Gongora R, et al. Comparative protein profiling identifies elongation factor-1beta and tryparedoxin peroxidase as factors associated with metastasis in Leishmania guyanensis. Mol Biochem Parasitol 2006; 145: 254-264.
23. Aisa MJ, Castillejo S, Gallego M, et al. Diagnostic potential of western blot analysis of sera from dogs with leishmaniasis in endemic areas and significance of the pattern. Am J Trop Med Hyg 1998; 58: 154-159.
24. Marty P, Lelievre A, Quaranta JF, Rahal A, Gari-Toussaint M & Le Fichoux Y. Use of the leishmanin skin test and western blot analysis for epidemiological studies in visceral leishmaniasis areas: experience in a highly endemic focus in Alpes-Maritimes (France). Trans R Soc Trop Med Hyg 1994; 88: 658-659.
25. Neogy AB, Vouldoukis I, Silva OA, et al. Serodiagnosis and screening of canine visceral leishmaniasis in endemic area of Corsica: applicability of a direct agglutination test and immunoblot analysis. Am J Trop Med Hyg 1992; 47: 772-777.
26. Palatnik de Sousa CB, Gomes EM, Paraguai de Souza E, et al. The FML (fucose mannose ligand) of Leishmania donovani. A new tool in diagnosis, prognosis, transfusional control and vaccination against human Kala-azar. Rev Soc Bras Med Trop 1996; 29: 153-163.
27. Zeyrek FY, Korkmaz M & Ozbel Y. Serodiagnosis of anthroponotic cutaneous leishmaniasis (ACL) caused by Leishmania tropica in Sanliurfa Province, Turkey, where ACL is highly endemic. Clin Vaccine Immunol 2007; 14: 1409-1415.